Pro Share Advisors LLC Summit Therapeutics Inc. Put Options Transaction History
Pro Share Advisors LLC
- $42.9 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SMMT
# of Institutions
238Shares Held
87.3MCall Options Held
1.77MPut Options Held
2.48M-
Baker Bros. Advisors LP New York, NY24.4MShares$650 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$310 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$210 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$175 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$129 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.35B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...